The FBN2 gene: new mutations, locus‐specific database (Universal Mutation Database FBN2), and genotype‐phenotype correlations
暂无分享,去创建一个
D. Milewicz | C. Béroud | H. Klein | G. Jondeau | C. Maslen | D. Hamroun | M. Claustres | G. Collod-Béroud | L. Faivre | C. Boileau | M. Frédéric | C. Binquet | Prateek Gupta | C. Marschall | L. Neumann | E. Gautier | M. Godfrey | C. Moñino
[1] M Claustres,et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.
[2] N. Matsumoto,et al. FBN2, FBN1, TGFBR1, and TGFBR2 analyses in congenital contractural arachnodactyly , 2007, American journal of medical genetics. Part A.
[3] Thierry Soussi,et al. UMD (Universal Mutation Database): 2005 update , 2005, Human mutation.
[4] J. Towbin,et al. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly , 2004, Journal of Medical Genetics.
[5] K. Holman,et al. Ectopia lentis phenotypes and the FBN1 gene , 2004, American journal of medical genetics. Part A.
[6] R. Mecham,et al. Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment. , 2003, The Biochemical journal.
[7] Gabor Matyas,et al. Update of the UMD‐FBN1 mutation database and creation of an FBN1 polymorphism database , 2003, Human mutation.
[8] Thierry Soussi,et al. The UMD‐p53 database: New mutations and analysis tools , 2003, Human mutation.
[9] D. Keene,et al. Fibrillins Can Co-assemble in Fibrils, but Fibrillin Fibril Composition Displays Cell-specific Differences* , 2003, The Journal of Biological Chemistry.
[10] D. Rifkin,et al. Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.
[11] A. Munnich,et al. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome , 2003, Journal of medical genetics.
[12] F. Quondamatteo,et al. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[13] Christophe Béroud,et al. The UMD‐LDLR database: additions to the software and 490 new entries to the database , 2002, Human mutation.
[14] C. Béroud,et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein , 2002, Human mutation.
[15] I. Kaitila,et al. Ten novel FBN2 mutations in congenital contractural arachnodactyly: Delineation of the molecular pathogenesis and clinical phenotype , 2002, Human mutation.
[16] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[17] R. Pagon,et al. Two novel fibrillin-2 mutations in congenital contractural arachnodactyly. , 2000, American journal of medical genetics.
[18] C Béroud,et al. UMD (Universal Mutation Database): A generic software to build and analyze locus‐specific databases , 2000, Human mutation.
[19] C Béroud,et al. p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis , 2000, Human mutation.
[20] R. Timpl,et al. Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. , 1999, Matrix biology : journal of the International Society for Matrix Biology.
[21] Qiwei Yang,et al. Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung. , 1999, Developmental biology.
[22] F. Ramirez,et al. The fibrillins. , 1999, The international journal of biochemistry & cell biology.
[23] D. Milewicz,et al. Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development. , 1998, American journal of medical genetics.
[24] U. Francke,et al. A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly , 1998, Human Genetics.
[25] P. Handford,et al. Solution structure of the transforming growth factor β‐binding protein‐like module, a domain associated with matrix fibrils , 1997, The EMBO journal.
[26] M. Raghunath,et al. A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. , 1997, American journal of human genetics.
[27] R. Hennekam,et al. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.
[28] J. Coselli,et al. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. , 1996, Circulation.
[29] C. Clericuzio,et al. Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. , 1996, American journal of human genetics.
[30] L. Peltonen,et al. A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome. , 1996, Genomics.
[31] I. Campbell,et al. Solution Structure of a Pair of Calcium-Binding Epidermal Growth Factor-like Domains: Implications for the Marfan Syndrome and Other Genetic Disorders , 1996, Cell.
[32] R. Mecham,et al. Analysis of the human gene encoding latent transforming growth factor-beta-binding protein-2. , 1996, The international journal of biochemistry & cell biology.
[33] K. Miyazono,et al. Efficient Association of an Amino-terminally Extended Form of Human Latent Transforming Growth Factor- Binding Protein with the Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.
[34] D. Milewicz,et al. Fibrillin–2 (FBN2) mutations result in the Marfan–like disorder, congenital contractural arachnodactyly , 1995, Nature Genetics.
[35] H. Dietz,et al. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. , 1995, Human molecular genetics.
[36] P. Handford,et al. The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions , 1995, Cell.
[37] D. Milewicz,et al. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.
[38] C. Price,et al. Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. , 1995, Human molecular genetics.
[39] R. Glanville,et al. Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. , 1994, The Journal of biological chemistry.
[40] R. Mecham,et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices , 1994, The Journal of cell biology.
[41] L. Peltonen,et al. A novel mutation of the fibrillin gene causing ectopia lentis. , 1994, Genomics.
[42] B. Sykes,et al. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. , 1993, Human molecular genetics.
[43] H. Dietz,et al. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. , 1993, Genomics.
[44] M. Raghunath,et al. Deficiencies of fibrillin and decorin in fibroblast cultures of a patient with neonatal Marfan syndrome. , 1992, Journal of medical genetics.
[45] D. Viljoen,et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. , 1992, The New England journal of medicine.
[46] M. Patterson,et al. Cardiac anomalies complicating congenital contractural arachnodactyly. , 1991, Archives of disease in childhood.
[47] M. Mattei,et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes , 1991, Nature.
[48] I. D. Campbell,et al. Key residues involved in calcium-binding motifs in EGF-like domains , 1991, Nature.
[49] P. Handford,et al. The role of beta‐hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. , 1988, The EMBO journal.
[50] J. Opitz,et al. A severe form of congenital contractural arachnodactyly in two newborn infants. , 1986, American journal of medical genetics.
[51] M. W. Bean. Congenital contractural arachnodactyly. , 1979, American journal of diseases of children.
[52] C. Lobeck,et al. THE CLINICAL SPECTRUM OF CONGENITAL CONTRACTURAL ARACHNODACTYLY: A CASE WITH CONGENITAL HEART DISEASE , 1974, Pediatric Research.
[53] J. Herrmann,et al. The clinical spectrum of congenital contractural arachnodactyly , 1974, Zeitschrift für Kinderheilkunde.
[54] F. Hecht,et al. Congenital contractural arachnodactyly. A heritable disorder of connective tissue. , 1971, The Journal of bone and joint surgery. American volume.
[55] J. Laugier,et al. [Marfan's disease and arthrogryposis. Apropos of a case in a newborn infant]. , 1969, Annales de pediatrie.
[56] F. Hecht,et al. Hereditary dysplasia of bone with kyphoscoliosis, contractures, and abnormally shaped ears. , 1968, The Journal of pediatrics.
[57] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[58] M. Raghunath,et al. Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts , 2004, Human Genetics.
[59] T. Nagase,et al. Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins. , 2001, DNA research : an international journal for rapid publication of reports on genes and genomes.
[60] C. Junien,et al. Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC , 1999, Human mutation.
[61] L. Pereira,et al. Molecules in focus: the fibrillins , 1999 .
[62] Christophe Béroud,et al. Software and database for the analysis of mutations in the VHL gene , 1998, Nucleic Acids Res..
[63] Christophe Béroud,et al. Software and database for the analysis of mutations in the human WT1 gene , 1998, Nucleic Acids Res..
[64] Hanns-Georg Klein,et al. Marfan Database (third edition): new mutations and new routines for the software , 1998, Nucleic Acids Res..
[65] Manfred Stuhrmann,et al. LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis , 1998, Nucleic Acids Res..
[66] Thierry Soussi,et al. P53 Gene Mutation: Software and Database , 1998, Nucleic Acids Res..
[67] Thierry Soussi,et al. p53 and APC gene mutations: software and databases , 1997, Nucleic Acids Res..
[68] Christophe Béroud,et al. Software and database for the analysis of mutations in the human LDL receptor gene , 1997, Nucleic Acids Res..
[69] G Collod-Béroud,et al. Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene , 1997, Nucleic Acids Res..
[70] Thierry Soussi,et al. Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene , 1997, Nucleic Acids Res..
[71] Thierry Soussi,et al. APC gene: database of germline and somatic mutations in human tumors and cell lines , 1996, Nucleic Acids Res..
[72] Thierry Soussi,et al. P53 Gene Mutation: Software and Database , 1996, Nucleic Acids Res..
[73] N. Nomura,et al. Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. , 1996, DNA research : an international journal for rapid publication of reports on genes and genomes.
[74] Rocco,et al. Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome. , 1995, The American journal of pathology.
[75] T. Sasaki,et al. Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardial cushion tissue and is a prominent component of valves in adult heart. , 1995, Developmental biology.
[76] J. Rosenbloom,et al. Fibrillin-1 and fibrillin-2 show temporal and tissue-specific regulation of expression in developing elastic tissues. , 1995, Connective tissue research.
[77] L. Peltonen,et al. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome , 1994, Nature Genetics.
[78] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.